Text Size
1 study found for:    Crenolanib AND GIST | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Crenolanib AND GIST | Open Studies (1 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Phase II Study of Crenolanib (CP-868,596), for the Treatment of Patients With Advanced Gastrointestinal Stromal Tumors With the D842-related Mutations and Deletions in the PDGFRA Gene
Condition: D842-related Mutant GIST
Intervention: Drug: Crenolanib besylate (CP-868,596-26), Dose: 140mg BID
To Top

† Indicates status has not been verified in more than two years